Wie hoch ist der Preis für Adcock Ingram Holdings Limited (AIP)

Preis für Adcock Ingram Holdings Limited (AIP) ist $4.38

Wie hoch ist die Marktkapitalisierung für Adcock Ingram Holdings Limited (AIP)

Marktkapitalisierung für Adcock Ingram Holdings Limited (AIP) ist $668.68M

Adcock Ingram Holdings Limited (AIP) Gewinne

Adcock Ingram Holdings Limited, established in 1890 and headquartered in Midrand, South Africa, operates as a global manufacturer, marketer, and distributor of diverse healthcare products. Its international footprint extends across South Africa, the United States, Canada, the United Kingdom, broader Europe, and other international regions. The company offers a comprehensive product portfolio, including over-the-counter (OTC) remedies, prescription medications, consumer health goods, and specialized medical instrumentation and surgical supplies. Its extensive pharmaceutical range covers numerous therapeutic classes, such as women's health, cannabidiol applications, antiretroviral treatments, dermatology, central nervous system disorders, respiratory conditions, ophthalmology, generic medicines, cardiovascular health, pain relief, gastroenterology, energy and immunity support (including colds and flu remedies, vitamins, minerals, and food/nutrition supplements), personal care, feminine hygiene, digestive well-being, allergy management, baby care, and cough solutions. Beyond its general healthcare offerings, Adcock Ingram also manufactures and supplies essential hospital and critical care products, such as intravenous solutions, renal dialysis systems, and blood collection supplies. The company serves both private and public sectors within the healthcare industry.

Jahr	Gewinn	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Gewinn

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Gewinn	Gewinnunterschied	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$1.76B	-	IN

Unternehmen

Gewinn

Gewinnunterschied

Land